Dr Reddy's Laboratories shares gained 2.7 percent intraday on July 1 after a media report indicated about approval for Srikakulam unit from Greek drug regulator.
The stock has rallied 15 percent in last one year, outperforming Nifty Pharma index that has lost 12 percent in the same period. It was quoting at Rs 2,613, up Rs 63.20, or 2.48 percent on the BSE at 1109 hours IST.
Dr Reddy's Srikakulam unit has received a clearance letter from Greek drug regulator, reported CNBC-TV18 quoting Cogencis.
The report further suggested that the company's Duvvada unit has received two observations from the US Food and Drug Administration, but which are largely procedural in nature.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.